Despite the reported association of KCNJ11 polymorphisms with increased risk of type 2 diabetes and pharmacogenetic responses to antidiabetic medications, their role in the regulation of kidney function appears to be minor [25]. This evidence concerns the gene KCNJ11 and type 2 diabetes mellitus.